Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003103808 | SCV000650726 | likely benign | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004559186 | SCV002724466 | likely benign | Dyskeratosis congenita | 2022-03-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004711171 | SCV005259071 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Ce |
RCV004711171 | SCV005436333 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | TERT: BP4, BP7 |